文献速递肾移植

原型分析识别与移植物存活相关的肾移植受者移植性肾小球病不同特征

Archetype Analysis Identifies Distinct Profiles in Renal Transplant Recipients with Transplant Glomerulopathy Associated with Allograft Survival.
PubMed 文献 · J Am Soc Nephrol · 2019-03-14

本研究纳入法国和加拿大四中心2004至2014年间诊断为移植性肾小球病(Banff cg≥1)的385例肾移植受者(552份活检,发生率6.7%),采用无监督原型分析整合临床、免疫及病理数据,识别出5种原型,其5年移植物存活率从88%到22%不等,并构建在线应用辅助临床风险分层。

要点

  • 移植性肾小球病异质性强,原型分析可区分5种不同特征和预后的亚型。
  • 不同原型5年移植物存活率差异显著(88%至22%),支持个体化风险分层。
  • 基于真实患者数据构建的在线应用可用于临床辅助决策。

核心结论

  • 无监督原型分析可细化移植性肾小球病的诊断和预后特征,减少异质性。
  • 识别出的5种原型具有不同的功能、免疫、组织学特征及移植物存活率。
  • 基于原型的风险分层有助于个体化治疗策略和临床试验优化。

研究设计与样本

  • 纳入标准为活检诊断移植性肾小球病(Banff cg评分≥1),共385例患者、552份活检样本。
  • 采用无监督原型分析整合全面的病理、临床、免疫及结局数据。

主要发现

  • 移植性肾小球病在8207份移植后活检中的发生率为6.7%(552份活检)。
  • 从移植到诊断移植性肾小球病的中位时间为33.18个月。
  • 诊断后3、5、7、10年肾移植物存活率分别为69.4%、57.1%、43.3%、25.5%。
  • 识别出5种原型,5年移植物存活率范围为88%至22%,差异显著。

临床怎么用

  • 原型分析可用于移植性肾小球病患者的个体化风险分层。
  • 基于真实患者构建的在线应用可辅助临床实践。
  • 原型分类可能指导未来治疗策略和临床试验设计。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Transplant glomerulopathy, a common glomerular lesion observed after kidney transplant that is associated with poor prognosis, is not a specific entity but rather the end stage of overlapping disease pathways. Its heterogeneity has not been precisely characterized to date. METHODS: Our study included consecutive kidney transplant recipients from three centers in France and one in Canada who presented with a diagnosis of transplant glomerulopathy (Banff cg score ≥1 by light microscopy), on the basis of biopsies performed from January of 2004 through December of 2014. We used an unsupervised archetype analysis of comprehensive pathology findings and clinical, immunologic, and outcome data to identify distinct groups of patients. RESULTS: Among the 8207 post-transplant allograft biopsies performed during the inclusion period, we identified 552 biopsy samples (from 385 patients) with transplant glomerulopathy (incidence of 6.7%). The median time from transplant to transplant glomerulopathy diagnosis was 33.18 months. Kidney allograft survival rates at 3, 5, 7, and 10 years after diagnosis were 69.4%, 57.1%, 43.3%, and 25.5%, respectively. An unsupervised learning method integrating clinical, functional, immunologic, and histologic parameters revealed five transplant glomerulopathy archetypes characterized by distinct functional, immunologic, and histologic features and associated causes and distinct allograft survival profiles. These archetypes showed significant differences in allograft outcomes, with allograft survival rates 5 years after diagnosis ranging from 88% to 22%. Based on those results, we built an online application, which can be used in clinical practice on the basis of real patients. CONCLUSIONS: A probabilistic data-driven archetype analysis approach applied in a large, well defined multicenter cohort refines the diagnostic and prognostic features associated with cases of transplant glomerulopathy. Reducing heterogeneity among such cases can improve disease characterization, enable patient-specific risk stratification, and open new avenues for archetype-based treatment strategies and clinical trials optimization.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Aubert O, Higgins S, Bouatou Y, et al. Archetype Analysis Identifies Distinct Profiles in Renal Transplant Recipients with Transplant Glomerulopathy Associated with Allograft Survival. J Am Soc Nephrol. 2019. PMID: 30872323. doi:10.1681/ASN.2018070777

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。